| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 449 | 2020 |
| “To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity S Cappelli, SB Randone, D Martinović, MM Tamas, K Pasalić, Y Allanore, ... Seminars in arthritis and rheumatism 41 (4), 589-598, 2012 | 208 | 2012 |
| Drug-induced vasculitis: a clinical and pathological review M Radic, D Martinovic Kaliterna, J Radic Neth J Med 70 (1), 12-17, 2012 | 174 | 2012 |
| Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study AY Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE ... Ann Rheum Dis. 75 (1), 103-9., 2016 | 155 | 2016 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. HE Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P Ann Rheum Dis. 75 (1), 163-9., 2016 | 139 | 2016 |
| Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials. FDE 39. Khanna D, Denton CP, Merkel PA, Krieg T, Le Brun FO, Marr A ... JAMA. 315 (18), 1975-88., 2016 | 127 | 2016 |
| Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study F Nacci, A Righi, ML Conforti, I Miniati, G Fiori, D Martinovic, D Melchiorre, ... Annals of the rheumatic diseases 66 (7), 977-979, 2007 | 102 | 2007 |
| Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. WUA 40. Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O ... Ann Rheum Dis. 75 (7), 1285-92, 2016 | 99 | 2016 |
| Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 93 | 2019 |
| Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. DO 42. Dobrota R, Maurer B, Graf N, Jordan S, Mihai C, Kowal-Bielecka O ... Ann Rheum Dis. 75 (10), 1743-8, 2016 | 80 | 2016 |
| Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis M Radic, D Martinovic Kaliterna, J Radic Neth J Med 68 (11), 348-53, 2010 | 56 | 2010 |
| Helicobacter pylori infection and systemic sclerosis–is there a link? M Radić, DM Kaliterna, J Radić Joint Bone Spine 78 (4), 337-340, 2011 | 46 | 2011 |
| Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK H Chinoy, F Salway, S John, N Fertig, BD Tait, CV Oddis, WER Ollier, ... Annals of the rheumatic diseases 66 (7), 970-973, 2007 | 46 | 2007 |
| Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? M Radić, DM Kaliterna, D Bonacin, JM Vergles, J Radić, D Fabijanić, ... Rheumatology international 33, 2943-2948, 2013 | 45 | 2013 |
| Relationship between interleukin-6 and cardiac involvement in systemic sclerosis Z Jurisic, D Martinovic-Kaliterna, D Marasovic-Krstulovic, D Perkovic, ... Rheumatology 52 (7), 1298-1302, 2013 | 39 | 2013 |
| Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis? D Marasovic-Krstulovic, D Martinovic-Kaliterna, D Fabijanic, ... Rheumatology 50 (8), 1505-1512, 2011 | 39 | 2011 |
| Correlation between Helicobacter pylori infection and systemic sclerosis activity M Radić, D Martinović Kaliterna, D Bonacin, J Morović Vergles, J Radić Rheumatology 49 (9), 1784-1785, 2010 | 36 | 2010 |
| Relationship between vitamin D, IFN-γ, and E2 levels in systemic lupus erythematosus. CV Kokic V, Martinovic Kaliterna D, Radic M, Perkovic D, Cvek M Lupus. 25 (3), 282-8., 2016 | 33 | 2016 |
| Vascular manifestations of systemic lupus erythematosis M Radic, D Martinovic Kaliterna, J Radic Neth J Med 71 (1), 10-6, 2013 | 32 | 2013 |
| Prevalence of systemic sclerosis in Split–Dalmatia county in Southern Croatia M Radić, DM Kaliterna, D Fabijanić, J Radić Clinical rheumatology 29, 419-421, 2010 | 31 | 2010 |
Jadranka Morovic-VerglesMedicinski fakultet ZagrebVerified email at kbd.hr
